Recombinant Human MMP-2 Protein, CF
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0429014-V3
- Awardee
- Bio-Techne Sales Corporation
- Contracting organization
- University of Virginia
- Cumulative value
- $466.00
About this award
The University of Virginia awarded contract A207_PO-0429014-V3 to Bio-Techne Sales Corporation on September 26, 2026, for the procurement of specialized research materials. The contract, valued at $466, involves the delivery of Recombinant Human Matrix Metalloproteinase-2 (MMP-2) Protein in its Catalytic Fragment (CF) form. The order encompasses 466 units at $1 per unit, with delivery designated to the buyer.
Bio-Techne Sales Corporation serves as the prime contractor for this procurement, which represents a straightforward purchase of laboratory reagents by the Virginia-based university. The contract reflects a standard transactional award for biological research materials commonly utilized in protein research and biomedical studies. No additional information regarding contract duration, performance period specifications, or annual value parameters is documented in the available award materials.
Line items
| Item | Total |
|---|---|
| Recombinant Human MMP-2 Protein, CF | $466.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0429014-V3?
Contract A207_PO-0429014-V3 was awarded to Bio-Techne Sales Corporation by University of Virginia on September 26, 2026.
How much is contract A207_PO-0429014-V3 worth?
Its cumulative value is $466.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award